Amplification of c-met is observed in 4–12% of gastric cancer patients and concomitant c-met and EGFR amplification (or overexpression of the respective proteins) has been reported in up to 6% of gastric cancer cases [21, 22]. The gene discussed is MET; the disease is gastric cancer.